Skip to main content

Key Patent Issued in Collaboration with Professor William Klein's Research

February 28, 2019

Bipharmaceutical company Qantu Therapeutics announced the issuance of a patent on their QT-0101 adjuvant that covers its use in vaccines against Alzheimer's disease. The vaccine under development is in collaboration with Professor William Klein and his team's "pioneering discoveries" in this area.

Read the full press release here.